Zhejiang Orient Gene Biotech Co., Ltd (SHA:688298)
China
· Delayed Price · Currency is CNY 22.95
-0.30 (-1.29%)
May 28, 2025, 3:00 PM CST
SHA:688298 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| Cash & Equivalents | 2,605 | - | 4,165 | 6,597 | 6,098 | 2,039 | Upgrade
|
| Short-Term Investments | - | - | - | - | 31.15 | - | Upgrade
|
| Trading Asset Securities | 328.9 | - | 1,052 | 1,161 | 168.07 | 199 | Upgrade
|
| Cash & Short-Term Investments | 2,934 | 3,707 | 5,217 | 7,758 | 6,297 | 2,238 | Upgrade
|
| Cash Growth | -34.80% | -28.95% | -32.75% | 23.19% | 181.43% | 2519.03% | Upgrade
|
| Accounts Receivable | 192.37 | - | 207.74 | 309.36 | 1,184 | 625.82 | Upgrade
|
| Other Receivables | 17.01 | - | 20.7 | 73.13 | 53.96 | 43.83 | Upgrade
|
| Receivables | 209.38 | - | 228.44 | 382.49 | 1,238 | 669.65 | Upgrade
|
| Inventory | 296.95 | - | 346.78 | 431.92 | 470.56 | 381.58 | Upgrade
|
| Other Current Assets | 143.87 | - | 104.01 | 175.42 | 120.06 | 30.5 | Upgrade
|
| Total Current Assets | 3,584 | - | 5,896 | 8,747 | 8,126 | 3,319 | Upgrade
|
| Property, Plant & Equipment | 2,815 | - | 2,261 | 1,074 | 481.34 | 162.39 | Upgrade
|
| Long-Term Investments | 26.27 | - | 52.35 | 35.59 | 25.45 | - | Upgrade
|
| Goodwill | - | - | - | - | 15.41 | - | Upgrade
|
| Other Intangible Assets | 670.75 | - | 478.81 | 481.24 | 111.48 | 14.13 | Upgrade
|
| Long-Term Deferred Tax Assets | 271.73 | - | 218.26 | 193.23 | 69.68 | 45.46 | Upgrade
|
| Long-Term Deferred Charges | 54.53 | - | 61.05 | 36.32 | 7.37 | 5.08 | Upgrade
|
| Other Long-Term Assets | 337.05 | - | 28.05 | 135.63 | 139.81 | 26.82 | Upgrade
|
| Total Assets | 7,759 | - | 8,996 | 10,704 | 8,977 | 3,573 | Upgrade
|
| Accounts Payable | 480.75 | - | 600.49 | 1,580 | 1,174 | 371.97 | Upgrade
|
| Accrued Expenses | 35.66 | - | 68.45 | 218.81 | 175.55 | 97.64 | Upgrade
|
| Short-Term Debt | 177.52 | - | 198.22 | - | - | - | Upgrade
|
| Current Portion of Long-Term Debt | - | - | 50.3 | - | - | - | Upgrade
|
| Current Portion of Leases | - | - | 15.86 | 3.55 | 5.84 | - | Upgrade
|
| Current Income Taxes Payable | 9.7 | - | 3.77 | 17.67 | 606.85 | 309.31 | Upgrade
|
| Current Unearned Revenue | 35.77 | - | 34.77 | 339.14 | 71.19 | 325.7 | Upgrade
|
| Other Current Liabilities | 147.32 | - | 113.93 | 119.24 | 25.4 | 8.38 | Upgrade
|
| Total Current Liabilities | 886.73 | - | 1,086 | 2,278 | 2,059 | 1,113 | Upgrade
|
| Long-Term Debt | 115.13 | - | 300 | 50 | - | - | Upgrade
|
| Long-Term Leases | 40.5 | - | 43.96 | 28.65 | 12.65 | - | Upgrade
|
| Long-Term Unearned Revenue | 34.45 | - | 10.75 | 17.46 | 17.01 | 8.8 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | - | 0.04 | 2.76 | - | - | Upgrade
|
| Other Long-Term Liabilities | 17.62 | - | 5.7 | 3.39 | - | - | Upgrade
|
| Total Liabilities | 1,094 | - | 1,446 | 2,381 | 2,088 | 1,122 | Upgrade
|
| Common Stock | 201.6 | - | 201.6 | 168 | 120 | 120 | Upgrade
|
| Additional Paid-In Capital | 397.89 | - | 395.42 | 436.32 | 549.21 | 549.21 | Upgrade
|
| Retained Earnings | 6,152 | - | 6,797 | 7,530 | 6,201 | 1,785 | Upgrade
|
| Comprehensive Income & Other | 47.08 | - | 42.37 | 28.27 | -12.72 | -7.76 | Upgrade
|
| Total Common Equity | 6,522 | 6,880 | 7,436 | 8,163 | 6,857 | 2,446 | Upgrade
|
| Minority Interest | 142.91 | - | 113.66 | 160.15 | 31.62 | 5.37 | Upgrade
|
| Shareholders' Equity | 6,665 | 7,051 | 7,550 | 8,323 | 6,889 | 2,451 | Upgrade
|
| Total Liabilities & Equity | 7,759 | - | 8,996 | 10,704 | 8,977 | 3,573 | Upgrade
|
| Total Debt | 333.15 | 564.1 | 608.33 | 82.2 | 18.49 | - | Upgrade
|
| Net Cash (Debt) | 2,601 | 3,142 | 4,609 | 7,675 | 6,279 | 2,238 | Upgrade
|
| Net Cash Growth | -33.10% | -31.81% | -39.95% | 22.24% | 180.61% | 3729.37% | Upgrade
|
| Net Cash Per Share | 13.24 | 15.97 | 22.84 | 38.08 | 31.14 | 11.34 | Upgrade
|
| Filing Date Shares Outstanding | 193.2 | 191.27 | 201.6 | 201.6 | 201.6 | 201.6 | Upgrade
|
| Total Common Shares Outstanding | 193.2 | 191.27 | 201.6 | 201.6 | 201.6 | 201.6 | Upgrade
|
| Working Capital | 2,697 | - | 4,810 | 6,469 | 6,068 | 2,206 | Upgrade
|
| Book Value Per Share | 33.76 | 35.61 | 36.89 | 40.49 | 34.01 | 12.13 | Upgrade
|
| Tangible Book Value | 5,851 | 6,112 | 6,957 | 7,682 | 6,730 | 2,432 | Upgrade
|
| Tangible Book Value Per Share | 30.29 | 31.64 | 34.51 | 38.10 | 33.38 | 12.06 | Upgrade
|
| Buildings | - | - | 1,296 | 586.6 | 243.61 | 93.73 | Upgrade
|
| Machinery | - | - | 360.52 | 262.56 | 177.03 | 38.6 | Upgrade
|
| Construction In Progress | - | - | 796.48 | 369.99 | 112.45 | 70.29 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.